Our group is adding two Containment Level 3 (CL3) laboratories at the Company’s York, UK HQ facilities, creating a Centre of Excellence for the EcowaterOS consortium as well as other initiatives across divisions.

New services for Modern Water clients will include standard tests associated with dangerous pathogens, including contagious infections as well as community detection of opioids. Future services will include real-time monitoring and identification of small and large molecules within the pharmaceutical sector during bio-processing. Retrofitting has begun with Modern Water equipment to add to the range of real-time surveillance services in Water Monitoring.

The Centre of Excellence expands on the successful product testing using Labskin with the SARS-CoV-2 virus with University of Aberdeen, Public Health England, University of Liverpool, Cork Institute of Technology and the work completed with industry partners including Dell Technologies, Unilever and the Water Rising Institute.

The CL3 laboratories will focus on further development alongside partners, such as the Aptamer Group, Tyndall Foundries and a number of undisclosed partners to investigate new variants of SARS-CoV-2 by adding a multiplex nano-chip to test for a range of infectious viruses and bacteria on a single chip for the MicrotoxPD range of equipment for detection and identification of SARS-CoV-2, E.coli, Legionella and Cryptosporidium.

About the author : Matthew O'Sullivan